Category: Adamas wins FDA nod for extended-release amantadine in PD-associated LID

Adamas wins FDA nod for extended-release amantadine in PD-associated LID

  1. Adamas wins FDA nod for extended-release amantadine in PD-associated LID  BioWorld Online
  2. Mid-Morning Market Update: Markets Open Higher; Big Lots Profit Tops Estimates  Nasdaq
  3. This Biotech Rose To A 19-Month High — What’s Prodding Shares?  Investor’s Business Daily
  4. Full coverage

from Business – Google News http://www.bioworld.com/content/adamas-wins-fda-nod-extended-release-amantadine-pd-associated-lid-0

Advertisements